The specific intracellular pathways involved in this phenomenon vary depending on the cancer type and cellular context but commonly include the activation of caspases, modulation of Bcl‐2 family proteins, disruption of mitochondrial function, and inhibition of various signaling pathways. Here, BCL2 is linked to cancer.